|
| Exchange Disseminated Time 04/05/2018 16:17:43 | Cadila Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on May 25, 2018, inter alia, to approve the audited financial results for the quarter / year ended on March 31, 2018 and to recommend dividend for the financial year ended on March 31, 2018.
Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain closed from May 14, 2018 to May 28, 2018 for all Directors and Designated Officers of the Company. |
|
|